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Background: Oxidative stress plays a key role in the etiology of male infertility. Significant alterations in the sperm
proteome are associated with poor semen quality. The aim of the present study was to examine if elevated levels
of reactive oxygen species cause an alteration in the proteomic profile of spermatozoa.
Methods: This prospective study consisted of 52 subjects: 32 infertile men and 20 normal donors. Seminal
ejaculates were classified as ROS+ or ROS- and evaluated for their proteomic profile. Samples were pooled and
subjected to LC-MS/MS analysis through in-solution digestion of proteins for peptide characterization. The
expression profile of proteins present in human spermatozoa was examined using proteomic and bioinformatic
analysis to elucidate the regulatory pathways of oxidative stress.
Results: Of the 74 proteins identified, 10 proteins with a 2-fold difference were overexpressed and 5 were
underexpressed in the ROS+ group; energy metabolism and regulation, carbohydrate metabolic processes such as
gluconeogenesis and glycolysis, protein modifications and oxidative stress regulation were some of the metabolic
processes affected in ROS+ group.
Conclusions: We have identified proteins involved in a variety of functions associated with response and
management of oxidative stress. In the present study we focused on proteins that showed a high degree of
differential expression and thus, have a greater impact on the fertilizing potential of the spermatozoa. While
proteomic analyses identified the potential biomarkers, further studies through Western Blot are necessary to
validate the biomarker status of the proteins in pathological conditions.
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Male-factor infertility contributes to 50% of infertile
couples worldwide, and while the causes are multifactorial,
current research has focused on oxidative stress. Specif-
ically, oxidative stress may lead to alterations in protein
expression levels in spermatozoa, causing molecular and
genetic defects. Research has already shown that oxidative
stress is associated with a variety of male infertility diagnosis
such as varicocele, idiopathic infertility, spinal cord injury,
prostatitis and leukocytospermia [1-8]. Varicocele is impli-
cated in 35% of men with primary infertility and in 80% of
infertile men with secondary infertility, and oxidative stress* Correspondence: Agarwaa@ccf.org
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reproduction in any medium, provided the oris one of the many causes of varicocele related infertility
[9-11]. Oxidative stress in men with varicocele is also asso-
ciated both with motility and grade of varicocele.
Understanding the protein profile of spermatozoa is
essential for identifying the protein alterations that occur
as a result of increased production of ROS and for better
diagnosis of male infertility. The development of 2-
dimensional-polyacrylamide gel electrophoresis (2-DE)
coupled with Western blot have aided in the identification
of proteins, in relation to sperm composition and function
[12,13]. Furthermore advancements in mass spectrometry
analyses of spermatozoa have broadened our knowledge
and aided in the identification of pivotal sperm proteins
[14,15]. Numerous studies have reported the presence of
proteins in studies involving human spermatozoa through
the implementation of proteomic techniques such as 2-l Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
Sharma et al. Reproductive Biology and Endocrinology 2013, 11:48 Page 2 of 18
http://www.rbej.com/content/11/1/48DE, liquid chromatography tandem mass spectrometry
(LC-MS/MS), matrix assisted laser desorption and
ionization- time of flight tandem mass spectrometry
(MALDI-TOF-MS/MS), and 2-dimensional difference
in gel electrophoresis (DIGE) [16-21].
In this comparative study, we employed LC- MS/ MS
and functional bioinformatic analyses to identify the
relative abundance of proteins in spermatozoa obtained
from seminal ejaculates of infertile men who were referred
to the andrology clinical laboratory for advanced semen
analysis (including parameters of oxidative stress such as
levels of ROS in spermatozoa, concentration of antioxidant
in the seminal plasma and the extent of DNA damage).
We also included healthy men with high and low levels
of ROS in their seminal ejaculates compared to those
with low levels of ROS. Oxidative stress plays a major
role in male infertility, but the crucial proteins that are
differentially expressed in ROS are not known. Under-
standing the role of these proteins is therefore important
in our understanding of the post-genomic events. It
will help identify potential proteins that could serve as
biomarkers to better manage and treat oxidative stress,
and consequently, male infertility.
Methods
The study was approved by the Institutional Review Board
of Cleveland Clinic and was conducted in accordance with
national and international guidelines. A total of 52 subjects
were enrolled in the study. Twenty healthy male volunteers
of unproven fertility (normal semen analysis results but had
not established a pregnancy) were selected on the basis of
normal semen analysis. Thirty two infertile men attending
our infertility clinic were referred to the andrology lab
for advanced semen parameters of oxidative stress. The
breakdown of the infertile subjects was as follows: primary
infertility: n = 25 (25/ 32; 78.1%); Secondary infertility: n = 7
(7/25; 28%). Of the 25 men with primary infertility, 64%
(16/ 25) had <2 years and 36% (9/ 25) >2 years. Clinical
varicocele (grade 1-2) was present in 10 (62.5%) of the 16
men who presented with <2 years of primary infertility and
in 5 (55.6%) of the 9 men with >2 years of primary infertility.
In the 7 patients with secondary infertility, 6 (85.7%) had a
clinical varicocele (grade 1-2).
Semen samples were collected by masturbation after 2-3
days of sexual abstinence and analyzed according to WHO
2010 criteria [22]. A complete semen analysis was performed
on both donors and patients and included both macroscopic
(volume, pH, color, viscosity, liquefaction time, split or
complete ejaculate) and microscopic parameters (concen-
tration, motility, morphology, round cells and peroxidase
or Endtz test). All subjects were also examined for levels of
reactive oxygen species (ROS) in the seminal ejaculate. The
remainder of the seminal ejaculate was frozen without any
cryoprotectant and stored at -55°C for proteomic analysis.Semen analysis
After liquefaction, complete semen analysis was performed
to evaluate the sperm parameters (sperm count, per-
centages motility and morphology), according to WHO
guidelines [22]. Semen analysis was done using a MicroCell
counting chamber (Vitrolife, San Diego, CA). Smears of
the raw semen were stained with a Diff-Quik kit (Baxter
Healthcare Corporation, Inc., McGaw Park, IL) for assess-
ment of sperm morphology according to WHO criteria.
Measurement of reactive oxygen species
In the freshly ejaculated and completely liquefied semen,
ROS levels were measured by a chemiluminescence assay
using luminol (5-amino-2, 3- dihydro-1, 4-phthalazinedione).
Test samples consisted of luminol (10 μL, 5 mM) and
400 μL of semen. Negative controls were prepared by
replacing the sperm suspension with phosphate buffered
saline. Chemiluminescence was measured for 15 min using
a Berthold luminometer (Autolumat Plus 953). Results
were expressed as relative light units (RLU)/sec/ × 106
sperm. Reference value for ROS – group was: <20
RLU/s/×106 sperm. ROS levels >20 RLU/s/×106 sperm
were considered positive [23].
Separation of spermatozoa and In-solution Digestion
of Proteins
We were interested in examining the effect of ROS levels
on the distribution / alteration of proteins in an effort to
understand the underlying mechanism of infertility. Based
on our published reference levels, all samples with ROS
levels below 20 RLU/sec/ × 106 sperm were considered to
be ROS – and those with ROS levels >20 RLU/sec/ × 106
sperm were considered to be ROS + [23]. For proteomic
analysis, frozen seminal ejaculates from both the donors
and patients were divided into 2 groups: ROS+ and ROS-,
irrespective of the subject’s clinical diagnoses. Samples were
centrifuge at 10,000 g for 10 minutes to pellet the sperm-
atozoa and the clear seminal plasma was discarded. Samples
were pooled into ROS+ and ROS – groups and solubilized
in lysis buffer containing 2% octyl-β-glucopyranoside,
100 mM dithiothreitol (DTT), 9.8 M urea and protease
inhibitors [12]. Spermatozoa samples were stored overnight
in the refrigerator to allow for complete lysis of the sperm-
atozoa. The samples were first precipitated in cold acetone,
solubilized in 6 M urea, reduced with DTT, and alkylated
with iodoacetamide. The samples were subsequently diluted
to give a urea concentration <2 M and then digested with
trypsin. The tryptic digestion was subjected to a C18 clean
up and then brought up in 50 μL of 1% acetic acid [12].
Liquid chromatography- Mass Spectrometer analysis
(LC-MS-MS)
The LC-MS/MS system was a Finnigan LTQ linear ion trap
mass spectrometer system (Thermo Finnigan). Ten μL
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performance liquid chromatography column (Phenomenex
Jupiter C18 reversed-phase capillary chromatography
column). Peptides were eluted from the column by an
acetonitrile/0.1% formic acid gradient at a flow rate of
0.25 μL/min. They were introduced into the source of
the mass spectrometer on-line. The microelectrospray
ion source was operated at 2.5 kV. The digest was
analyzed using the data dependent multitask capability
of the instrument acquiring full scan mass spectra to
determine peptide molecular weights and product ion
spectra to determine amino acid sequence in successive
instrument scans [12].
Data analysis
The data were analyzed using all collision- induced dissoci-
ation spectra collected in the experiment to search the
National Center for Biotechnology Information (NCBI)
human reference sequence database with the search pro-
gram MASCOT (Matrix Science, Boston, MA). Mascot is a
mass spectral search algorithm that uses mass spectrometry
data to identify proteins from primary sequence databases.
These searches were used to identify the proteins present
in the in-solution digestions. After identification, a database
consisting of all proteins identified in these searches was
created and used for a second set of searches performed
with SEQUEST (Thermo Finnigan). SEQUEST is a tandem
mass spectrometry data analysis program used for protein
identification. Sequest identifies collections of tandem mass
spectra to peptide sequences that have been generated from
databases of protein sequences. The results from these
SEQUEST searches were used to determine the spectral
counts. These spectral count values were normalized by the
total number of spectral counts for all proteins in the sam-
ple and the number of amino acids present in the protein.
As the precision of the proteomic analysis has an average
error of 10-20%, a 2-fold change in protein expression was
considered significant.
Furthermore functional bioinformatics analysis were
done using publicly available (Gene Ontology (GO) anno-
tations from GO Term Finder [24] and GO Term Mapper
[25], UNIPROT [26], STRAP [27] and BioGPS [28] and
proprietary software packages (Ingenuity Pathway Analysis
(IPA) from IngenuityW Systems [29] and Metacore™ from
GeneGo Inc. [30] to identify the differentially affected
processes, pathways, interactions and cellular distribution
of the proteins in the two study groups.
Results
Semen parameters and oxidative stress parameters
Most of the infertile men were diagnosed with primary
infertility and varicocele. The median and 25th and 75th
percentile for sperm concentration (×106/ mL) in controls
was 64.9 (45.4-74.9) versus patients 23.0 (13.0-41.4).The median and 25th and 75th percentile motility in
controls was 58.3(50.0-65.7) compared to infertile men
50.5 (36.8-58.0). Among the patients, 46.8% (15/32)
had > 1 × 106 round cells / mL compared to donors
35% (7/20) of the donors, of these 15 patients, 15.6%
were positive for the Endtz test – a marker for
granulocytes, which are the major contributors of ROS
production. None of the donors was positive for the
Endtz test. An overlap in morphology was seen in both
the donors (3.5% ± 1.6%) and infertile men (3.6% ± 3.2%).
Among the patients 22 of 32 (68.8%) were positive for
ROS compared to 9 of 20 (45%) in the controls. Levels
of ROS were significantly lower (RLU/s/×106 sperm)
median and 25th and 75th percentile were seen in donors
[4.4(0, 300.2)] compared to infertile men [104(0, 1341)].
Among the primary infertility patients with <2 years of in-
fertility, 80% were positive for ROS and 55.6% were positive
in the patients with >2 years of primary infertility. A signifi-
cantly larger percentage of men (83%) were positive for
ROS in those with secondary infertility. Teratozoospermia
was present in 48% of men with primary infertility.
When all subjects were categorized into ROS+ and ROS-
groups, ROS levels (RLU/s/106sperm: median, 25th, 75th
percentile) were significantly different and higher in
the ROS+ group [2236(33, 4439)] group compared to the
ROS – group [4 (0, 9); P < 0.01)].
MS identification of the differentially expressed proteins
in ROS+ and ROS- samples
In this study, we analyzed the differential expression of
proteins in spermatozoa obtained from seminal ejaculates
with high levels of ROS+ and those with normal levels
(ROS-). Tables 1 and 2 show the primary proteins with
their NCBI database index number, calculated molecular
weight, isoelectric point (pI), peptide coverage and Mascot
scores for ROS+ and ROS- groups. Based on the SEQUEST
score, a total of 74 proteins were identified and differential
expression was calculated based on the normalized spectral
count ratios between ROS+ and ROS-. In the ROS+ group,
proteins that had >50% peptide coverage were: A-Kinase
anchor protein 4 isoform 2; Lactotransferrin precursor;
Tubulin, beta, 2; Tubulin, beta 4; Tubulin, alpha 3c;
Ropporin, rhophilin associated protein 1B; Prolactin-
induced protein; Histone cluster 1, H2aa; Beta actin and
Triosephosphate isomerase 1 isoform 1. In the ROS- group,
proteins that had >50% peptide coverage were: A-Kinase
anchor protein 4 isoform 2; Lactotransferrin precursor;
Spermatogenic Tubulin, beta, 2 precursor; Tubulin, beta 4;
Tubulin, alpha 3c; Ropporin, rhophilin associated protein
1B; Prolactin-induced protein; Histone cluster 1, H2aa and
Triosephosphate isomerase 1 isoform 1;
Out of the total 74 proteins identified, 47 were
overexpressed and 27 underexpressed in the ROS+ group;
15 proteins were significantly (2-fold) differentially









1 A-Kinase anchor protein 4 isoform 2 21493039 94 6.7 34 (54%) 10988
2 lactotransferrin precursor 54607120 80 8.5 36 (64%) 7287
3 tubulin, beta, 2 5174735 50 4.7 24 (68%) 6702
4 tubulin, beta 4 21361322 50 4.8 19 (57%) 5071
5 glyceraldehyde-3-phosphate dehydrogenase, spermatogenic 7657116 44 8.4 12 (48%) 5711
6 tubulin, alpha 3c 17921993 50 4.9 15 (51%) 2942
7 ropporin, rhophilin associated protein 1B 59891409 24 5.1 7 (56%) 2587
8 semenogelin II precursor 4506885 65 9.1 13 (22%) 2277
9 outer dense fiber of sperm tails 2 isoform 2 24430183 73 7.2 16 (31%) 2051
10 semenogelin I isoform a preproprotein 4506883 52 9.3 12 (31%) 1983
11 sperm protein associated with the nucleus,
X chromosome, family member C
13435137 11 5.0 3 (45%) 1892
12 tubulin, alpha, ubiquitous 57013276 50 4.9 13 (46%) 1616
13 glutathione S-transferase mu 3 23065552 26 5.3 7 (37%) 1595
14 prolactin-induced protein 4505821 16 8.2 8 (62%) 1559
15 A Kinase anchor protein 3 21493041 95 5.8 20 (35%) 1416
16 histone cluster 1, H2ba 24586679 14 10.3 1 (11%) 1371
17 mitochondrial malate dehydrogenase precursor 21735621 35 8.9 8 (33%) 1342
18 histone cluster 1, H2aa 25092737 14 10.8 6 (58%) 1334
19 clusterin isoform 1 42716297 58 6.2 6 (16%) 1204
20 ropporin 21359920 24 5.5 6 (43%) 1184
21 sorbitol dehydrogenase 156627571 38 8.2 7 (35%) 1095
22 mitochondrial ATP synthase beta subunit precursor 32189394 56 5.2 16 (53%) 976
23 beta actin 4501885 42 5.2 9 (54%) 909
24 triosephosphate isomerase 1 isoform 1 4507645 26 6.4 9 (55%) 761
25 glyceraldehyde-3-phosphate dehydrogenase 7669492 36 8.5 6 (32%) 706
26 L-lactate dehydrogenase C– 1 peptide 4504973 36 7.0 1 (5%) 674
27 fatty acid synthase 41872631 275 6.0 3 (8%) 669
28 sperm autoantigenic protein 17 8394343 17 4.7 2 (22%) 592
29 pyruvate kinase, muscle isoform M2 33286418 58 7.9 11 (38%) 560
30 ATP synthase, H + transporting, mitochondrial F1 complex,
alpha subunit precursor
4757810 59 9.1 8 (23%) 542
31 brain creatine kinase 21536286 42 5.3 7 (32%) 511
32 heat shock protein 90 kDa beta, member 1 4507677 92 4.7 6 (10%) 502
33 heat shock 70 kDa protein 2 13676857 70 5.5 10 (21%) 448
34 heat shock 90 kDa protein 1, alpha isoform 1 153792590 98 5.0 8 (13%) 447
35 saccharopine dehydrogenase (putative) 55770836 47 9.2 5 (29%) 395
36 actin, alpha 1, skeletal muscle 4501881 42 5.2 6 (36%) 374
37 glutamine synthetase 19923206 42 6.4 3 (9%) 374
38 fructose-bisphosphate aldolase A 4557305 39 8.3 5 (29%) 366
39 eukaryotic translation elongation factor 1 alpha 1 4503471 50 9.1 8 (36%) 347
40 fibronectin 1 isoform 3 preproprotein 16933542 262 5.4 6 (4%) 321
41 prostate, ovary, testis expressed protein on chromosome 2 153791352 123 5.8 4 (8%) 317
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Table 1 Protein name, NCBI database index number, calculated MW, pI, peptide coverage and Mascot score in ROS+ group
(Continued)
42 acetyl-Coenzyme A acetyltransferase 1 precursor 4557237 45 8.9 9 (33%) 316
43 voltage-dependent anion channel 2 42476281 32 7.4 4 (22%) 293
44 outer dense fiber of sperm tails 1 194248060 30 8.4 4 (26%) 283
45 phosphoglycerate kinase 2 31543397 45 8.7 5 (30%) 253
46 histone cluster 1, H2ae 10645195 14 11.0 4 (49%) 251
47 protein disulfide – isomerase A3 precursor 21361657 57 5.9 4 (13%) 243
48 acid phosphatase, prostate short isoform precursor 6382064 44 5.8 5 (16%) 240
49 voltage-dependent anion channel 3 isoform b 25188179 30 8.8 5 (27%) 226
50 phospholipase A2, group IIA precursor 4505849 16 9.4 2 (23%) 202
51 transglutaminase 4 (prostate) 156627577 77 6.3 8 (17%) 187
52 glutathione peroxidase 4 isoform A precursor 75709200 22 8.6 4 (32%) 181
53 heat shock 70 kDa protein 5 16507237 72 5.0 4 (8%) 161
54 heat shock protein beta-1 4504517 22 5.9 3 (31%) 160
55 angiotensin I converting enzyme 1 isoform 1 precursor 4503273 150 5.9 3 (4%) 160
56 peroxiredoxin 6 4758638 25 6.0 2 (16%) 145
57 chaperonin containing TCP1, subunit 5 (epsilon) 24307939 60 5.4 4 (12%) 142
58 valosin-containing protein 6005942 89 5.1 3 (7%) 142
59 sperm acrosomal membrane protein 14 – 1 peptide 19424138 13 5.4 1 (11%) 132
60 chaperonin containing TCP1, subunit 8 (theta) 48762932 60 5.4 4 (14%) 131
61 L-lactate dehydrogenase A isoform 1 5031857 36 8.4 2 (13%) 124
62 phosphoglycerate dehydrogenase 23308577 57 6.2 3 (13%) 112
63 clathrin heavy chain 1 4758012 193 5.4 4 (5%) 108
64 chaperonin containing TCP1, subunit 4 (delta) 38455427 58 7.9 5 (21%) 99
65 peptidylprolyl isomerase A 10863927 18 7.6 2 (23%) 96
66 fumarate hydratase precursor 19743875 54 8.8 8 (31%) 92
67 RAB2A, member RAS oncogene family 4506365 23 6.0 3 (18%) 92
68 olfactomedin 4 precursor 32313593 57 5.5 2 (5%) 90
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ROS- samples.
Of the differentially expressed proteins, 15 proteins
were overexpressed in the ROS+ samples while 5 were
underexpressed in comparison to ROS- samples (Table 3).
The overexpressed proteins included the histone cluster1;
H2ba (HIST1H2BA); mitochondrial malate dehydrogenase
precursor (MDH2); heat shock protein 90 kDa beta,
member 1 (HSP90B1); heat shock 70 kDa protein 5
(HSPA5); glutamine synthetase (GLUL); transglutaminase
4 (prostate) (TGM4); glutathione peroxidase 4 isoform
A precursor (GPX4); sperm acrosomal membrane protein
14 (SPACA4); olfactomedin 4 precursor (OLFM4) and
chromosome 20 open reading frame 3 (C20orf3). Proteins
that were found to be under expressed were: semenogelin
II precursor (SEMG2); peroxiredoxin 6 (PRDX6); clathrin
heavy chain 1 (CLTC); eukaryotic translation elongation
factor 2 (EEF2) and enolase 1 (ENO1).Gene ontology annotations of the proteins identified in
ROS+ and ROS- samples
The cellular distributions of the 74 proteins present in
the ROS+ and ROS- samples showed that there was a
greater distribution of proteins in the intracellular region
compared to the extracellular region (Figure 1A). A
significant number of proteins were also distributed in
the cytoplasmic region. The proteins involved in the
biological processes showed a greater distribution in
cellular processes (21%) followed by metabolic processes
(17%) (Figure 1B).
Gene ontology annotation comparisons of the differentially
expressed proteins in ROS+ and ROS- samples
Based on the Gene Ontology classifications, the majority
of the differentially expressed proteins that were over or
underexpressed in ROS+ group compared to the ROS-
group were localized to the cytoplasmic and intracellular







Peptides (Coverage) Mascot score
1 A-Kinase anchor protein 4 isoform 2 21493039 94 6.7 34 (54%) 11284
2 lactotransferrin precursor 54607120 80 8.5 32 (56%) 6049
3 gyceraldehyde-3-phosphate dehydrogenase, 7657116 44 8.4 12 (48%) 5959
4 spermatogenic tubulin, beta, 2 precursor 5174735 50 4.7 25 (68%) 5842
5 semenogelin I isoform a preproprotein 4506883 52 9.3 11(24%) 4965
6 tubulin, beta 4 21361322 50 4.8 19 (58%) 4879
7 semenogelin II precursor 4506885 65 9.1 15 (25%) 4205
8 tubulin, alpha 3c 17921993 50 4.9 15 (56%) 2645
9 ropporin, rhophilin associated protein 1B 59891409 24 5.1 6 (53%) 2427
10 prolactin-induced protein 4505821 16 8.2 8 (62%) 2164
11 A-kinase anchor protein 3 21493041 95 5.8 16 (28%) 1800
12 outer dense fiber of sperm tails 2 Isoform 2 24430183 73 7.2 16 (31%) 1722
13 sperm protein associated with the Nucleus,
X chromosome, family Member C
13435137 11 5.0 3 (45%) 1437
14 tubulin alpha 6 14389309 50 4.9 11 (45%) 1374
15 ropporin 21359920 24 5.5 6 (43%) 1280
16 clusterin isoform 1 42716297 58 6.2 5 (15%) 1257
17 sorbitol dehydrogenase 156627571 38 8.2 4 (23%) 1249
18 beta actin 4501885 42 5.2 6 (34%) 1232
19 pyruvate kinase, muscle isoform M1 3328642 58 7.6 13 (47%) 1133
20 histone cluster 1, H2aa 25092737 14 10.8 4 (51%) 1121
21 mitochondrial ATP synthase beta subunit precursor 32189394 56 5.2 13 (38%) 1031
22 fatty acid synthase 41872631 275 6.0 10 (9%) 935
23 glutathione S-transferase mu 3 23065552 26 5.3 7 (32%) 929
24 histone cluster 1, H2ba -1 peptide 24586679 14 10.3 1 (11%) 823
25 fibronectin 1 isoform 3 preproprotein 16933542 262 5.4 16 (11%) 790
26 L-lactate dehydrogenase C 4504973 36 7.0 2 (7%) 693
27 heat shock 90 kDa protein 1, alpha isoform 2 154146191 85 4.9 10 (18%) 682
28 glyceraldehyde-3-phosphate dehydrogenase 7669492 36 8.5 3 (15%) 621
29 sperm autoantigenic protein 17 8394343 17 4.7 2 (22%) 552
30 triosephosphate isomerase 1 isoform 1 4507645 26 6.4 6 (61%) 530
31 mitochondrial malate dehydrogenase precursor 21735621 35 8.9 5 (23%) 512
32 phosphoglycerate kinase 2 31543397 45 8.7 4 (17%) 506
33 heat shock 70 kDa protein 2 13676857 70 5.5 8 (22%) 423
34 histone cluster 1, H2ae 10645195 14 11.0 3 (43%) 392
35 acetyl-Coenzyme A acetyltransferase 1 precursor 4557237 45 8.9 8 (34%) 388
36 eukaryotic translation elongation factor 1 alpha 1 4503471 50 9.1 7 (30%) 383
37 ATP synthase, H + transporting, mitochondrial F1
complex, alpha subunit precursor
4757810 59 9.1 8 (22%) 378
38 outer dense fiber of sperm tails 1 194248060 30 8.4 3 (22%) 334
39 voltage-dependent anion channel 2 42476281 32 7.4 3 (19%) 332
40 acid phosphatase, prostate short isoform precursor 6382064 44 5.8 5 (16%) 326
41 brain creatine kinase 21536286 42 5.3 7 (29%) 268
42 saccharopine dehydrogenase (putative) 55770836 47 9.2 4 (29%) 265
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Table 2 Protein name, NCBI database index number, calculated MW, pI, peptide coverage and Mascot score in ROS- group
(Continued)
43 protein disulfide-isomerase A3 precursor 21361657 57 5.9 2 (9%) 261
44 eukaryotic translation elongation factor 2 4503483 96 6.4 3 (8%) 261
45 heat shock protein 90 kDa beta, member 1 4507677 92 4.7 5 (8%) 250
46 heat shock protein beta-1 4504517 22 5.9 4 (36%) 191
47 glutamine synthetase 19923206 42 6.4 3 (14%) 179
48 valosin-containing protein 6005942 89 5.1 7 (18%) 177
49 phospholipase A2, group IIA precursor 4505849 16 9.4 2 (23%) 170
50 tyrosine 3/tryptophan 5 -monooxygenase activation
protein, zeta polypeptide
4507953 27 4.7 2 (19%) 167
51 L-lactate dehydrogenase A isoform 1 5031857 36 8.4 2 (7%) 167
52 fructose-bisphosphate aldolase A 4557305 39 8.3 3 (16%) 167
53 chaperonin containing TCP1, subunit 5 (epsilon) 24307939 60 5.4 3 (9%) 157
54 voltage-dependent anion channel 3 isoform b 25188179 30 8.8 4 (26%) 147
55 peroxiredoxin 6 4758638 25 6.0 4 (33%) 140
56 glutathione peroxidase 4 isoform A precursor 75709200 22 8.6 5 (43%) 139
57 transglutaminase 4 (prostate) 156627577 77 6.3 5 (9%) 136
58 enolase 1 4503571 47 7.0 3 (12%) 134
59 T-complex protein 1 isoform b 57863259 44 7.5 5 (30%) 129
60 CSE1 chromosome segregation 1-like protein 29029559 111 5.5 2 (3%) 128
61 fumarate hydratase precursor 19743875 54 8.8 3 (12%) 115
62 lectin, mannose-binding 2 precursor 5803023 40 6.4 2 (13%) 115
63 clathrin heavy chain 1 4758012 193 5.4 6 (7%) 111
64 chaperonin containing TCP1, subunit 4 (delta) 38455427 58 7.9 4 (19%) 107
65 RAB2A, member RAS oncogene family 4506365 23 6.0 3 (18%) 106
66 chromosome 20 open reading frame 3 24308201 46 5.8 3 (19%) 105
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of intracellular, organelle, macromolecular complex region
and mitochondria were predominantly occupied by
the overexpressed proteins. The cytosolic, cytoplasm,
extracellular, plasma membrane, protein complex and the
vesicular region showed an abundance of underexpressed
proteins when compared to the overexpressed ones.
Strikingly, the endosome, lipid particle, membrane-bound
organelles and the microtubules showed only the presence
of overexpressed proteins in the ROS+ group while the
proteinaceous extracellular matrix was restricted only to
the underexpressed proteins.
GO analysis also revealed that the majority of over and
under expressed proteins in the ROS+ group was found
to be involved in cellular processes (Figure 3). The
proteins involved in developmental processes, cellular
process, interactions with cells and organisms, localization,
metabolic processes and transport were common to both
under and overexpressed proteins. Overexpressed proteins
were abundantly expressed for these functions. Many of the
processes such as cellular amino acid metabolic processes,
cellular component biogenesis, chromosome organization,cytoskeleton organization, embryo development, gluconeo-
genesis and homeostatic processes were found to be
restricted only to the overexpressed proteins. Similarly,
the processes such as carbohydrate catabolic processes,
cellular component movement, glycolysis, and response
to unfolded protein were found to be restricted to the
underexpressed proteins.
Pathways and network analysis of differentially expressed
in ROS+ proteins using Ingenuity Pathway Analysis (IPA)
and Metacore™ software packages
A list of significantly enriched or topmost pathways
and/or process networks associated with the over and
underexpressed proteins in the ROS+ group is shown in
Table 3. Cellular processes were comprised of cell cycle,
cell adhesion, cellular morphology, cellular movement
and cell death and cell survival. Protein modifications
included protein folding and degradation; general
metabolic pathways were: carbohydrate metabolism
(such as glycolysis and gluconeogenesis), amino acid
metabolism, energy metabolism and oxidative stress
regulation. With respect to the pathways related to
Table 3 Differentially expressed proteins in ROS- and ROS+ groups along with the spectral count and the spectral
count ratio for the two groups
Protein NCBI # SC ROS- NSC-ROS- SC ROS+ NSC-ROS+ NSC ratio in
ROS+/ROS-
acetyl-Coenzyme A acetyltransferase 1 precursor (ACAT1) 4557237 20 0.006 26.000 0.008 1.4
acid phosphatase, prostate short isoform precursor (ACPP) 6382064 17 0.005 27.000 0.009 1.7
actin, alpha 1, skeletal muscle (ACTA1) 4501881 0 0.000 8.000 0.003 ROS + only
A-kinase anchor protein 3 (AKAP3) 21493041 76 0.022 70.000 0.022 1.0
A-kinase anchor protein 4 isoform 2 (AKAP4) 21493039 497 0.145 467.000 0.147 1.0
angiotensin I converting enzyme 1 isoform 1 precursor (ACE) 4503273 5 0.001 5.000 0.002 1.1
ATP synthase, H + transporting, mitochondrial F1 complex,
alpha subunit precursor (ATP5A1)
4757810 28 0.008 30.000 0.009 1.2
beta actin (ACTB) 4501885 53 0.015 36.000 0.011 0.7
brain creatine kinase (CKB) 21536286 19 0.006 21.000 0.007 1.2
chaperonin containing TCP1, subunit 4 (delta) (CCT4) 38455427 4 0.001 6.000 0.002 1.6
chaperonin containing TCP1, subunit 5 (epsilon) (CCT8) 24307939 4 0.001 7.000 0.002 1.9
chaperonin containing TCP1, subunit 8 (theta) 48762932 5 0.001 4.000 0.001 0.9
chromosome 20 open reading frame 3 (C20orf3) 24308201 2 0.001 4.000 0.001 2.2
clathrin heavy chain 1 (CLTC) 4758012 14 0.004 6.000 0.002 0.5
clusterin preproprotein (CLU) 355594753 56 0.016 55.000 0.017 1.1
CSE1 chromosome segregation 1-like protein (CSE1L) 29029559 3 0.001 0.000 0.000 ROS- only
enolase 1 (ENO1) 4503571 7 0.002 2.000 0.001 0.3
eukaryotic translation elongation factor 1 alpha 1 (EEF1A1) 4503471 28 0.008 33.000 0.010 1.3
eukaryotic translation elongation factor 2 (EEF2) 4503483 12 0.003 5.000 0.002 0.5
fatty acid synthase (FASN) 41872631 40 0.012 35.000 0.011 1.0
fibronectin 1 isoform 3 preproprotein (FN1) 16933542 41 0.012 21.000 0.007 0.6
fructose-bisphosphate aldolase A (ALDOA) 4557305 15 0.004 17.000 0.005 1.2
fumarate hydratase precursor (FH) 19743875 5 0.001 7.000 0.002 1.5
glutamine synthetase (GLUL) 19923206 4 0.001 12.000 0.004 3.2
glutathione peroxidase 4 isoform A precursor (GPX4) 75709200 8 0.002 21.000 0.007 2.8
glutathione S-transferase mu 3 (GSTM3) 23065552 50 0.015 65.000 0.020 1.4
glyceraldehyde-3-phosphate dehydrogenase (GAPDH) 7669492 14 0.004 22.000 0.007 1.7
glyceraldehyde-3-phosphate dehydrogenase, spermatogenic (GAPDHS) 7657116 210 0.061 185.000 0.058 1.0
heat shock 70 kDa protein 2 (HSPA2) 13676857 26 0.008 22.000 0.007 0.9
heat shock 70 kDa protein 5 (HSPA5) 16507237 5 0.001 11.000 0.003 2.4
heat shock 90 kDa protein 1, alpha isoform 1 (HSP90AA1) 153792590 39 0.011 26.000 0.008 0.7
heat shock protein 90 kDa beta, member 1 (HSP90B1) 4507677 11 0.003 22.000 0.007 2.2
heat shock protein beta-1 (HSPB1) 4504517 5 0.001 4.000 0.001 0.9
histone cluster 1, H2aa (HIST1H2AA) 25092737 47 0.014 56.000 0.018 1.3
histone cluster 1, H2ae (HISTH1AE) 10645195 14 0.004 13.000 0.004 1.0
histone cluster 1, H2ba (HIST1H2BA) 24586679 22 0.006 49.000 0.015 2.4
lactotransferrin precursor (LTF) 54607120 246 0.072 292.000 0.092 1.3
lectin, mannose-binding 2 precursor 5803023 3 0.001 5.000 0.002 1.8
L-lactate dehydrogenase A isoform 1 (LDHA) 5031857 10 0.003 9.000 0.003 1.0
L-lactate dehydrogenase C (LDHC) 4504973 17 0.005 12.000 0.004 0.8
mitochondrial ATP synthase beta subunit precursor (ATP5B) 32189394 50 0.015 70.000 0.022 1.5
mitochondrial malate dehydrogenase precursor (MDH2) 21735621 22 0.006 44.000 0.014 2.2
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Table 3 Differentially expressed proteins in ROS- and ROS+ groups along with the spectral count and the spectral
count ratio for the two groups (Continued)
olfactomedin 4 precursor (OLFM4) 32313593 1 0.000 4.000 0.001 4.3
outer dense fiber of sperm tails 1 (ODF1) 194248060 15 0.004 14.000 0.004 1.0
outer dense fiber of sperm tails 2 isoform 2 (ODF2) 24430183 90 0.026 91.000 0.029 1.1
peptidylprolyl isomerase A (PPIA) 10863927 4 0.001 2.000 0.001 0.5
peroxiredoxin 6 (PRDX6) 4758638 4 0.001 1.000 0.0003 0.3
phosphoglycerate dehydrogenase (PHGDH) 23308577 3 0.001 5.000 0.002 1.8
phosphoglycerate kinase 2 (PGK2) 31543397 17 0.005 9.000 0.003 0.6
phospholipase A2, group IIA precursor (PLA2G2A) 4505849 6 0.002 10.000 0.003 1.8
prolactin-induced protein (PIP) 4505821 118 0.034 101.000 0.032 0.9
prostate specific antigen isoform 1 preproprotein (KLK3) 4502173 3 0.001 2.000 0.001 0.7
protein disulfide-isomerase A3 precursor (PDIA3) 21361657 7 0.002 7.000 0.002 1.1
pyruvate kinase, muscle isoform M2 (PKM) 33286418 49 0.014 31.000 0.010 0.7
RAB2A, member RAS oncogene family (RAB2A) 4506365 3 0.001 3.000 0.001 1.1
ropporin (ROPN1) 21359920 20 0.006 31.000 0.010 1.7
ropporin, rhophilin associated protein 1B (ROPN1B) 59891409 73 0.021 73.000 0.023 1.1
saccharopine dehydrogenase (putative) (SCCPDH) 55770836 13 0.004 16.000 0.005 1.3
semenogelin I isoform a preproprotein (SEMG1) 4506883 171 0.050 101.000 0.032 0.6
semenogelin II precursor (SEMG2) 4506885 513 0.149 226.000 0.071 0.5
sorbitol dehydrogenase (SORD) 156627571 36 0.010 27.000 0.009 0.8
sperm acrosomal membrane protein 14 19424138 1 0.000 2.000 0.001 2.2
sperm autoantigenic protein 17 (SPA17) 8394343 15 0.004 20.000 0.006 1.4
sperm protein associated with the nucleus,
X chromosome, family member C (SPANX)
13435137 54 0.016 80.000 0.025 1.6
transglutaminase 4 (prostate) (TGM4) 156627577 4 0.001 9.000 0.003 2.4
triosephosphate isomerase 1 isoform 1 (TPI1) 4507645 28 0.008 31.000 0.010 1.2
tubulin alpha 6 (TUBA1C) 14389309 9 0.003 11.000 0.003 1.3
tubulin, alpha 3c (TUBA3C) 17921993 117 0.034 134.000 0.042 1.2
tubulin, beta 4 (TUBB4A) 21361322 36 0.010 30.000 0.009 0.9
tubulin, beta, 2 (TUBB4B) 5174735 232 0.068 235.000 0.074 1.1
tyrosine 3/tryptophan 5 -monooxygenase
activation protein, zeta polypeptide (YWHAZ)
4507953 4 0.001 3.000 0.001 0.8
valosin-containing protein (VCP) 6005942 16 0.005 9.000 0.003 0.6
voltage-dependent anion channel 2 (VDAC2) 42476281 11 0.003 11.000 0.003 1.1
voltage-dependent anion channel 3 isoform b 25188179 7 0.002 12.000 0.004 1.9
A cut-off of 2-fold difference in NSC ratio was considered as significantly differentially expressed in ROS+. Overexpressed and underexpressed proteins are shown in bold.
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genesis and glycolysis including phosphoglycerate kinase 2
(PGK2) and glyceraldehyde phosphate dehydrogenase-S
(GAPD-S) were found to be underexpressed in the
ROS+ group for both gluconeogenesis and glycolysis
while glyceraldehyde-3-phosphate dehydrogenase (GAPDH),
fructose-biphosphate aldolase A(ALDOA) and mitochon-
drial malate dehydrogenase precursor (MDH2) were
overexpressed. The overexpressed proteins, especially
in the glycolytic pathway, were triosephosphate isom-
erase 1 (isoform 1(TPI1), glyceraldehyde-3 phosphatedehydrogenase (GAPDH) and fructose-biphosphate aldolase
A (ALDOA). Two enzymes involved in the fermentation of
pyruvate to lactate – L-lactate dehydrogenase C (LDHC)
and L-lactate dehydrogenase A isoform 1(LDHA) were
underexpressed. In addition, two enzymes functional in
sucrose degradation pathways - triosephosphate isomerase
1 (TPI1) and fructose biphosphate aldolase A (ALDO A),
were overexpressed.
Transcriptional regulatory network analysis of the differ-
entially expressed proteins, using Metacore™, showed that








































Figure 1 Functional annotations from consolidated publicly available software tools A: Cellular distribution showing the maximum
distribution was intracellular (22%) followed by cytoplasmic distribution; B: Biological processes distribution of proteins identified in
spermatozoa from ROS+ and ROS- group showing the highest distribution was in the cellular processes (21%) followed by metabolic
processes.
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interacting with the receptor (Figure 4). As a result of the
established connection between germ cell development and
the levels of androgens, it was important to elucidate the
potential interaction of these over- and underexpressed
proteins with the androgen receptor. One of the pathways
that may be relevant to spermatogenesis is cAMP re-
sponsive element modulator (CREM) signaling in the
testis (Figure 5). In this pathway, 3 proteins were found
to be differentially expressed. Angiotensin I converting
isoform 1 precursor (ACE). The outer dense fiber of sperm
tails 1 (ODF1) was found to be underexpressed whereas the
L- lactate dehydrogenase C (LDHC) was overexpressed in
ROS+ sample compared with ROS- sample.
Discussion
Oxidative stress plays a key role in the etiology of male infer-
tility, possibly by altering protein expression levels in sperm-
atozoa, causing molecular and genetic defects. Therefore,
understanding the function of each protein involved and the
post-translational modifications that occur during sperm-
maturation is important and may lead to a useful biomarkerfor male infertility. In earlier studies, we demonstrated that
ROS are independent of the semen parameters [6]. There-
fore, in the current study, we compared the sperm proteome
from a group of men with high levels of ROS (ROS+) with
that from men with low or physiological levels of ROS
(ROS-). The ROS grouping was done irrespective of the pa-
tient’s clinical diagnoses and semen parameters: the only
criteria was the presence or absence of ROS.
We have identified 74 proteins, 15 of which had a >2-fold
difference in their expression levels in the ROS+ group
when compared to the ROS- group. Based on the spec-
tral counts of the 74 proteins, we identified 47 were
overexpressed and 27 that were underexpressed in the
ROS+ group compared to the ROS- group. Of the 74
proteins, 17 were determined to be either in their
precursor or pre-protein form. The presence of these
incompletely processed proteins is indicative of post-
translational processing problems as reported by some
investigators [31,32]. Accumulation of precursor forms of
protein may result in deregulation of the downstream
functions of the mature protein [31]. Oxidative stress may
result in the accumulation of precursors or preproteins.
Figure 2 Cellular distribution showing the proteins that were significantly overexpressed in ROS + group were located in the cytoplasm,
intracellular, organelle and membrane-bound organelle and underexpressed in ROS + group were located in the cytoplasm, cytosol,
intracellular and organellar.
Sharma et al. Reproductive Biology and Endocrinology 2013, 11:48 Page 11 of 18
http://www.rbej.com/content/11/1/48The cellular distribution of all the proteins as ascertained
by GO analysis (Figure 1A) suggested that the majority of
the proteins (68 proteins) were intracellular or organellar
(62 proteins) in origin, whereas a few were localized in
the extracellular (13 proteins) region. The presence of
extracellular proteins may be attributed to the presence of
round cells in the ejaculate from both the donors and
patients. We did not remove these from subsequent
processing for proteomic analysis.Similar comparative studies have been performed previ-
ously by other groups in an effort to understand the sperm
proteome [31,33,34]. Most notable amongst these are two
studies where the expression profile of proteins was com-
pared in asthenozoospermic and normozoospermic donors
[31,33]. In these studies, 10 proteins and 17 spots were iden-
tified using 2-DE suggesting their role in motility-related
male infertility. Xu et al conducted a comparative study be-
tween infertile patients and normozoospermic group and
Figure 3 Biological process distribution of proteins of overexpressed were cellular processes, metabolic processes, localization,
regulation and transport in spermatozoa from ROS + compared to cellular preocesses, regulation, response to stress, cellular
movement and glycolysis in ROS- group.
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potentially serve as diagnostic markers in identifying the
underlying pathology of male infertility [35]. Our findings
in this study are novel, as we have compared and identi-
fied the proteins that are differentially expressed in sperm-
atozoa obtained from seminal ejaculates with high levels
of ROS (ROS+) to those normal levels of ROS (ROS-).On examining the association of the differen-
tially expressed proteins with the biological processes
(Figure 1B), we concluded that the majority of the pro-
teins were involved in cellular, metabolic, and regulatory
processes. A smaller distribution of proteins (3-5%) was
also found in biological processes such as de novo post
translational (8 proteins) and protein folding (14 proteins),
Figure 4 Transcriptional regulatory network showing interactions between differentially expressed ROS + proteins and androgen receptor.
Proteins with red or blue circles around them are over-expressed (HSPA5 and TGM4) or underexpressed (PRDX6) in spermatozoa from the ROS +
(relative to ROS-) group. The levels of expression values are reflected in the intensity of red or blue colors. Green arrows with a hexagon indicate
positive effect. TR = Transcription regulation; PGK2 = phosphoglycerate kinase 2; GAPD-S = glyceraldehyde phosphate dehydrogenase-S; GAPDH=
glyceraldehyde-3-phosphate dehydrogenase; ALDOA = fructose-biphosphate aldolase A; and MDH2=mitochondrial malate dehydrogenase precursor.
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list of proteins, by the GO Term Finder.
Even though the spermatozoa become transcriptionally
inactive after spermatogenesis, we found the presence
of the translational proteins and this may be indicative
of the presence of some leftovers from inefficient
spermatogenesis. They may also have a role in the normal
physiology of the spermatozoa or affect fertilization and
embryo development. Further validation through the
pathway and process network analysis using IPA and
Metacore™, suggested that the topmost function of the
differentially expressed proteins was carbohydrate me-
tabolism and included pathways of gluconeogenesis,
glycolysis, fermentation of pyruvate to lactate and sucrose
degradation. There is a great controversy pertaining to the
major pathway of energy metabolism during sperm motility
[36-39]. In this context, our findings showed that while
oxidative phosphorylation is important for sperm function,
the major pathway for energy production for sperm
motility was via the glycolytic pathway. To support this
view, various respiratory enzymes involved in the
glycolytic pathway including phosphoglycerate kinase
2 (PGK2), glyceraldehyde-3phosphate dehydrogenase
(GAPDH), fructose- biphosphate aldolase A (ALDOA),
glyceraldehyde-3 phosphate dehydrogenase-S (GAPDHS),
triosephosphate isomerase 1 isoform (TPI1) wereidentified in our study. Furthermore, GAPDH-S protein
was overexpressed in the ROS+ sample. Oxidation of
GAPDH-S as a result of H2O2 generation has been
reported to decrease sperm motility and inhibit GAPDH-S
activity [40].
Various isoforms of histone proteins were also identified
and these included histone cluster 1, H2aa (HIST1H2AA),
histone cluster1 H2ae (HISTH1AE) and histone cluster1
and H2ba (HIST1H2BA). Histones are a group of proteins
that are replaced by the protamines during sperm matur-
ation in the epididymal region [41]. Their presence in the
ejaculated spermatozoa is indicative of improper packaging
of sperm chromatin and subsequent DNA damage. These
findings have been attributed to oxidative stress [5,41].
We found 17 precursor proteins to be dysregulated; of
these, 10 were over-expressed and 5 were underexpressed
with a 2-fold difference between the ROS+ and ROS-
groups. The differentially expressed proteins were mainly
intracellular, cytoplasmic or organellar in distribution. This
is contrary to the findings of Xu et al, who reported a
higher distribution of differentially expressed proteins in
the extracellular region in the infertile groups with normal
semen parameters [35]. This difference may be attributed
to the import/export of epididymal and seminal vesicle
proteins. Furthermore, the distribution of overexpressed
and underexpressed proteins in the ROS+ group revealed
Figure 5 CREM signaling in the testis. Proteins in red or blue are the ones over or underexpressed in spermatozoa from the ROS + compared
to ROS- group. The color levels in the tubes reflect their expression levels (red-overexpressed and blue underexpressed). B = Binding; Z = catalysis;
T = transformation and TR = transcription regulation. The figure shows the generic enxzymes (Adenylate cyclase, LDHC, ACE1, HXK2); Protein
kinases (PKA-cat (cAMP –dependent and TSSK2); CREM activators and repressors; generic binding proteins (ACT, CPB and Tnp1 and PKA-reg
(cAMP –dependent) and proteins (HILS1 and ODF1) involved in the CREM signaling in the testis. CREM = cAMP responsive element modulator;
ACE = Angiotensin I converting isoform 1 precursor; ODF1 = outer dense fiber of sperm tails 1; LDHC = L- lactate dehydrogenase C.
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many proteins showing significant changes in expression
between the ROS+ and ROS- groups had roles in sexual
reproduction, metabolic processes and stress response
(Figures 2 and 3).
Our data suggests that semenogelin II precursor
(SEMG2), which is involved in sexual reproduction, was
underexpressed in the ROS+ group. Overexpression of
semenogelin I and II precursor has been reported in
previous comparative studies [31,35]. Xu et al reported an
increase in both isoforms of semenogelin in the spermato-
zoa of infertile patients compared to the normozoospermic
men [35]. Semenogelin -1 and semenogelin -2 have been
reported in men with varicocele only as well as in men with
varicocele with a history of moderate as well as heavy
smoking. Semenogelin is known to cause a decrease in
sperm motility, but it was within the normal range in theROS+ samples. Semenogelin (SEMG) is the major protein
of seminal fluid proteins (20-40%) and is secreted from
seminal vesicles, epididymis, and prostate [42,43]. It is an
androgen dependent protein that exists in two forms I
(52 kDa) and II (71-76 kDa). SEMG helps in the formation
of the semen coagulum that is degraded later by prostate-
specific antigen. SEMG counteracts oxidative stress by
reducing the generation of free radicals through several
mechanisms: slow sperm motility of the entrapped sperm,
reduced energy consumption, free radical generation and
inhibition of superoxide radical generation through direct
interference with sperm NADH oxidase [44].
A great number of proteins are involved in the energy
production required for the spermatozoon tail movement.
We identified several proteins that are involved in energy
producing processes such as the carbohydrate metabolic
pathways of glycolysis and gluconeogenesis. Enolase I
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while respiratory enzyme mitochondrial malate dehydro-
genase precursor (MDH2) was found to be overexpressed.
MDH2 is an ROS producing enzyme localized in the
sperm mitochondria [45]. It catalyzes the last step of the
Krebs cycle when malate is converted into oxaloacetate
using NAD+/NADH as intermediates. Several of the
chaperone proteins such as heat shock protein 90 kDa
beta, member 1 (HSP90B1) and heat shock 70 kDa
protein 5 (HSPA5) were also seen to be overexpressed
in response to stress. The association of these proteins with
various processes related to cellular stressors such as heat,
glucose deprivation, free radical attack, and infection
indicates that ROS induces a stress response in the
spermatozoa [46-48].
The GO annotations further revealed the involvement
of overexpressed proteins in cellular amino acid metabolic
processes. Examples of proteins that were found to be
overexpressed included transglutaminases (TGM4) and
glutamine synthetases. Transglutaminases are a family
of calcium-dependent enzymes that catalyze the post-
translational modification of the selected glutamine
residues on proteins by cross-linking with the peptide-
bound lysine residues or incorporating polyamines [49,50].
Transglutaminase that is secreted from the prostate is
known as TGM4 prostate. A recent study showed increased
levels of transglutaminase in response to oxidative stress in
the prostate [51]. Excessive production of ROS has been
reported to induce cell senescence, oxidative protein modi-
fications, and cell membrane damage, increase intracellular
calcium and activate certain cytokines such as TGFb [51].
Oxidative stress impacts the aggregation, increased
molecular weight, unfolding, denaturation and proteolysis
of cellular proteins. These effects may result in the initi-
ation of cellular hyperamonemia, which probably triggers
the expression of glutamate synthetase to redirect the
production of the released ammonium into glutamate [52].
Glutathione peroxidase 4 isoform A precursor (GPX4)
and peroxiredoxin 6 (PRDX6) function to reduce oxidative
stress. The former was overexpressed and the latter was
underexpressed in the ROS+ group. GPX4 is a well-known
antioxidant enzyme and its increased expression in sperm
in the ROS+ samples is reflective of its influence on genes
synthesizing this enzyme. PRDX6 also belongs to a family
of antioxidant enzyme known as peroxiredoxins. They de-
toxify H2O2 similar to catalase or glutathione peroxidases
(GPXs) [53,54]. Peroxiredoxin 6 is localized in the sperm
head (postacrosomal region and equatorial segment)
and sperm tail [55]. Reduced levels of peroxiredoxins
(PRDX1 and PRDX6) have been reported in infertile
men with oxidative stress. Reduced levels of PRDX6
have also been reported in the seminal plasma from men
with varicocele. Differential amounts of peroxiredoxin 6
have been reported (41% in men with varicocele and 65%in men with idiopathic infertility) [56]. Human spermatozoa
are reported to have high sensitivity to ROS and may be a
result of reduced recycling of peroxiredoxins after exposure
to oxidative stress [55].
Optimal levels of expression and function of androgens
are central to the process of spermatogenesis. To under-
stand the dependency of the differentially expressed
proteins in the ROS+ groups, a network was derived to
identify proteins regulated by androgen receptors. Sperm-
atogenesis is dependent on androgen action and androgens
act by stimulating the receptors present on the Sertoli cells
[57,58]. Transcriptional network analysis (Figure 4) showed
that 21 proteins were regulated by the androgen receptor.
In our study, several proteins appeared to be transcription-
ally activated by the androgen receptor but the effect of
the androgen receptor on several other proteins is still
unknown (Figure 5). Stanton et al reported that any loss
to the androgen stimulus during meiosis induces changes
in the proteins that are associated with various molecular
processes such as apoptosis, cell signaling, oxidative stress
and RNA processing [58]. These investigators further
validated this observation by immunostaining for oxidized
DNA adducts – they showed that spermatocytes that
undergo oxidative stress induced DNA damage during an-
drogen suppression. The completion of meiosis requires
androgen action via the Sertoli cell [59]. Low levels of
testicular androgens support meiosis while a high level
is required for spermiogenesis.
Testicular testosterone suppression has been shown to
adversely influence antioxidant activity [60]. The present
study utilizing Network analysis revealed heat shock
protein beta-1 (HSPB1) and clathrin heavy chain 1 (CLTC),
which are known to bind and activate androgen receptor
were actually underexpressed in the ROS+ group. We also
observed that GAPDH levels were overexpressed, and that
it was bound with the androgen receptor to impart a stimu-
latory effect in the ROS+ sample. The mechanism by which
the androgen stimulus is transduced by the Sertoli cell to
the germ cells is still unclear. In addition, it is well known
that in majority of the infertility cases attributed to a male
factor, spermatogenic arrest is a common feature. The
process of spermatogenesis is dependent on the cAMP
responsive element modulator (CREM) signaling pathway
in the testis which operates in coordination with the CREM
modulators (repressors and activators) [61]. CREM is
essential for male fertility and the absence of CREM-
dependent transcription in post-meiotic germ cells is
known to result in an arrest of spermatid differentiation
and apoptosis [62,63]. CREM repressors are expressed
during pre-meiotic germ cells while CREM activators are
expressed in the post-meiotic germ cells. In order to
understand the impact of oxidative stress on impaired
spermatogenesis, we examined the CREM signaling in
testis. Our findings revealed that three of the identified
Sharma et al. Reproductive Biology and Endocrinology 2013, 11:48 Page 16 of 18
http://www.rbej.com/content/11/1/48proteins that were differentially expressed in the ROS+
group were modulated by CREM activators. This included
ODF1 and ACE1 proteins that were underexpressed as
well LDHC, which was overexpressed. These findings sug-
gest that oxidative stress may affect the switching of genes
at the spermatogenic level. Comparative studies on CREM
signaling in testis have been conducted on normo- and
oligozoospermic men and men with round spermatids vs.
round spermatid maturation arrest [64]. These findings
further support the fact that a lack of a switch in the
expression of CREM gene isoforms may have an adverse
impact on spermatogenesis in humans.
To summarize, in this study, we have identified various
proteins that are implicated in a multitude of functions asso-
ciated with response and management of oxidative stress.
The increased expression of histone cluster 1H2ba
(HIST1H2BA), mitochondrial malate dehydrogenase pre-
cursor (MDH2), transglutaminase 4 (TGM4), glutathione
peroxidase 4 isoform A precursor (GPX4), glutamine syn-
thetase (GLUL), heat shock proteins (HSP90B1 and HSPA5)
in the ROS+ sample suggests that these proteins can serve
as potential biomarkers of oxidative stress. Thus alterations
reported in our study in men with and without oxidative
stress may help explain pathways leading to the altered
semen phenotype especially in men exhibiting oxidative
stress both in infertile men as well as in infertile men with
varicocele. However, the interaction between the proteins
and the androgen receptors is still unclear and warrants fur-
ther investigation. It is important to accurately assess the
protein levels and verify that the differentially expressed pro-
teins are indeed involved in the process of oxidative stress
and are possibly modified as a result of oxidative stress. In
future studies, as a follow-up to the present study, quantita-
tive estimation of the differentially (overexpressed and
underexpressed) expressed proteins, utilizing western blot-
ting and antibodies is warranted. The findings of our study
provide the groundwork for further testing including the
proposition that these newly identified sperm proteins play
crucial roles in oxidative stress and the pathophysiology of
male infertility.
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